The Cancer Letter
@TheCancerLetter
The leading independent source for information on the issues that shape #oncology since 1973. Editor: @PaulBGoldberg | Assoc. editor: @mattobh | @cancerhistproj
08-03-2009 17:32:44
8,6K Tweets
24,9K Followers
1,5K Following
To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria. Guest editorial by Julia Beaver, Thomas Uldrick, MD, Gwynn, Suanna Bruinooge, Caroline Schenkel, Edward S. Kim, MD, MBA, FACP, FASCO.
cancerletter.com/guest-editoria…